Adiposity as a risk factor of non alcoholic fat diesease; systematic review;La adiposidad como factor de riesgo del hígado graso no alcohólico; revisión sistemática

Nutricion Hospitalaria

Volumn 29, Issue 4, 2014, Pages 771-775

  Jiménez Cruz, Arturo ^a   Gómez Miranda, Luis Mario ^a   Ramírez, Glenda Díaz ^b   Meza, Nuris Yohana Carvalí ^a   Bacardí Gascón, Montserrat ^a  

^a UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

^b Economics Department   (United States)

Author keywords

Adiposity; Body mass index; NAFLD; Obesity; Waist circumgerence

Indexed keywords

FEMALE; HUMAN; MALE; META ANALYSIS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RISK FACTOR;

ADIPOSITY; FEMALE; HUMANS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; RISK FACTORS;

EID: 84897940458     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2014.29.4.7216     Document Type: Review

References (31)

1. Lizardi Cervera J, Becerra Laparra I, Chávez Tapia NC, Ramos Ostos ME, Uribe Esquivel M. Prevalencia de hígado graso no alcohólico y síndrome metabólico en población asintomática. Rev Gastroenterol Mex 2006; Oct-Dic; 71 (4).
2. Huang SC, Yang YJ. Serum retinol-binding protein 4 is independently associated with pediatric NAFLD and fasting triglyceride level. J Pediatr Gastroenterol Nutr 2013 Feb; 56 (2): 145-50.
3. Zhou YJ, Li YY, Nie YQ, Ma JX, Lu LG, Shi SL, Chen MH, Hu PJ. Prevalence of fatty liver disease and its risk factors in the population of South China. World J Gastroenterol 2007 Dec 21; 13 (47): 6419-24.
4. Bernal Reyes R. Hígado graso no alcohólico. Revista de Gastroenterología de México 2011; (Supl. 1) (76): 156-8.
5. Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liverdisease. Circulation 2008 Jul 15; 118 (3): 277-83.
6. Yoo HJ, Park MS, Lee CH, Yang SJ, Kim TN, Lim KI, Kang HJ, Song W, Yeon JE, Baik SH, Choi DS, Choi KM. Cutoff points of abdominal obesity indices in screening for non-alcoholic fatty liver disease in Asians. Liver Int 2010 Sep, 30 (8): 1189-96.
7. Pérez Lorenzo M, Duarte Castillo N, Montero González T, Franco Estrada S, Winograd Lay R, Brizuela Quintanilla RA. Prevalencia del hígado graso no alcohólico en muestras de biopsias hepáticas. Rev Cub Med Mil 2006; 35 (4): 1-8.
8. Gómez Miranda LM, Jiménez-Cruz A, Bacardí-Gascón M. Estudios aleatorizados sobre el efecto del consumo de bebidas azucaradas sobre la adiposidad en adolescentes y adultos. Revisión sistemática. Nutr Hosp 2013; 28 (6): 1792-6.
9. Jiménez Cruz A, Gómez Miranda LM, Bacardí Gascón M. Estudios aleatorizados sobre el consumo de bebidas azucaradas sobre la adiposidad en menores de 16 años. Revisión sistemática. Nutr Hosp 2013; 28 (6): 1797-801.
10. Kumashiro N, Erion DM, Zhang D, Kahn M, Beddow SA, Chu X, Still SD, Gerhard GS, Han X, James Dziura, Kitt Falk Petersen, Varman T. Samuel, Gerald I. Shulman Cellular mechanism of insulin resistance in nonalcoholic fatty liver disease. Biological Sciences - Medical Sciences 2011; 108 (39) 16381-85.
11. Rhee EJ, Lee WY, Cho YK, Kim BI, Sung KC. Hyperinsulinemia and the development of nonalcoholic Fatty liver disease in nondiabetic adults. Am J Med 2011 Jan; 124 (1): 69-76.
12. Candia R, Riquelme A, Baudrand R y cols. Potential role of over expression of 11 -hydroxysteroid dehydrogenasa Type 1 in visceral adipose tissue and portal hypercortisolism in the pathogenesis of non-alcoholic fatty liver disease. Sesión de trabajos libres orales presentada en DDW 2011; mayo 7-10; Chicago, Il. 736.
13. Estep JM, Sharma H, Vernon G y cols. Expression level of IL- 20, mTOR, IL- 13RA1, and SEMA4C are increased in the visceral adipose tissue of patients with non-alcoholic steatohepatitis while there is decrease in the expression levels of their regulatory mirnas. Sesión de carteles presentada en DDW 2011; mayo 7-10; Chicago, Il. Tu 1905.
14. Mohanty SR, Troy TN, Huo D. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease. J Hepatol 2009 Apr; 50 (4): 797-804.
15. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, Grundy SM, Hobbs HH. Prevalence of hepatic steatosis in an urban population in the United States: of ethnicity. Hepatology 2004 Dec; 40 (6): 1387-95.
16. Williams CD, Stengel J, Asike MI, Torres DM Shaw J, Contreras M, Landt CT, Harrison SA. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middleaged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 2011 Jan; 140 (1): 124-31.
17. De Luis DA, Aller R, Izaola O, González Sagrado M, Conde R. Efecto de dos dietas hipocalóricas en los niveles de transaminasas y resistencia a la insulina en pacientes obesos con hígado graso no alcohólico. Nutr Hosp 2010; 25: 5.
18. Castro Martínez MG, Banderas Lares DZ, Ramírez Martínez JC, Escobedo de la Peña J. Prevalencia de hígado graso no alcohólico en individuos con síndrome metabólico. Cir 2012; 80: 128-33.
19. Lu H, Liu H, Hu F, Zou L, Luo S, and Sun L. Independent Association between Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: A Systematic Review and Meta-Analysis. Int J Endocrinol 2013; Article ID 124958, 7 pages.
20. Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso- Coello P, Montori V, Akl EA, Djulbegovic B, Falck-Ytter Y, Norris SL, Williams JW Jr, Atkins D, Meerpohl J, Schünemann HJ. GRADE guidelines: 4. Rating the quality of evidence -study limitations (risk of bias). J Clin Epidemiol 2011 Apr; 64 (4): 407-15.
21. Guyatt GH, Oxman AD, Sultan S, Glasziou P, Akl EA, Alonso- Coello P, Atkins D, Kunz R, Brozek J, Montori V, Jaeschke R, Rind D, Dahm P, Meerpohl J, Vist G, Berliner E, Norris S, Falck-Ytter Y, Murad MH, Schünemann HJ. GRADE Working Group., GRADE guidelines: 9. Rating up the quality of evidence. J Clin Epidemiol 2011; 64 (12): 1311-6.
22. Xu C, Yu C, Ma H, Xu L, Miao M and Li Y, Prevalence and Risk Factors for the Development of Nonalcoholic Fatty Liver Disease in a Nonobese Chinese Population: the Zhejiang Zhenhai Study. Am J Gastroenterol 2013; Aug108 (8): 1299-304.
23. Zelber-Sagi S, Lotan R, Shlomai A, Web M, Harrari G, Buch A, Nitzan Kaluski D, Halpern Z, Oren R. Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up. J Hepatol 2012 May; 56 (5): 1145-51.
24. Xu C, Yu C, Xu L, Miao M, Li Y. High Serum Uric Acid Increases the Risk for Nonalcoholic Fatty Liver Disease: A Prospective Observational Study. 2010; PLoS ONE Jul14;5 (7): e11578.
25. Hamaguchi M, Kojima T, Takeda N, Nakagawa T, Taniguchi H, Fujii K, Omatsu T, Nakajima T, Sarui H, Shimazaki M, Kato T, Okuda J, Ida K. The Metabolic Syndrome as a Predictor of Nonalcoholic Fatty Liver Disease. Ann Intern Med 2005 Nov; 143 (10): 722-8.
26. Musso G, Cassader M, Bo S, De Michieli F, Gambino R. Sterol Regulatory Element-Binding Factor 2 (SREBF-2) Predicts 7- Year NAFLD Incidence and Severity of Liver Disease and Lipoprotein and Glucose Dysmetabolism. Diabetes 2013 Apr; 62 (4): 1109-20.
27. Hong HC, Hwang SY, Choi H Y, Yoo HJ, Seo JA, Kim SG, Kim NH, Baik SH, Choi DS, Choi KM. The Relationship between Sarcopenia and Non-Alcoholic Fatty Liver Disease: The Korean Sarcopenic Obesity Study. Hepatology 2013 Aug 31. [Epub ahead of print]
28. Targher G and Byrne CD. Nonalcoholic Fatty Liver Disease: a Novel Cardiometabolic Risk Factor for Type 2 Diabetes and Its Complications. J Clin Endocrinol Metab 2013 Feb; 98 (2): 483-95.
29. Ghamar-Chehreh ME, Khedmat H, Amini M, Taheri S. Predictive value of having positive family history of cardiovascular disorders, diabetes mellitus, dyslipidemia, and hypertension in non-alcoholic fatty liver disease patients. Acta Med Iran 2013 May 30; 51 (5): 307-13.
30. Ahmed MH, Barakat S, Almobarak AO. Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Has the Time Come for Cardiologists to Be Hepatologists? J Obes 2012; 2012: 483135.
31. Targher G, Bertolini L, Poli F, Rodella S, Scala L, Tessari R, Zenari L, Falezza G. Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes 2005 Dec; 54 (12): 3541-6.